XTLB
XTL Biopharmaceuticals
XTLB
XTLB
3 hedge funds and large institutions have $378K invested in XTL Biopharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$1K |
Top Sellers
| 1 |
1
Jane Street
New York
|
$0 |
| 2 |
U
2
UBS
Zurich,
Switzerland
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $376K | 129,811 | – | – |
|
2
Ameriprise
Minneapolis,
Minnesota
| $1K | 441 | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $1K | 351 | +351 | New |
|
|
4
Jane Street
New York
| – | – | -10,693 | Closed |
|
|
U
5
UBS
Zurich,
Switzerland
| – | – | -400 | Closed |
|